# Subcutaneous Immunoglobulin in De-novo CIDP (SIDEC)

> **NCT04589299** · PHASE4 · RECRUITING · sponsor: **University of Aarhus** · enrollment: 60 (estimated)

## Conditions studied

- CIDP - Chronic Inflammatory Demyelinating Polyneuropathy

## Interventions

- **BIOLOGICAL:** Immunoglobulin

## Key facts

- **NCT ID:** NCT04589299
- **Lead sponsor:** University of Aarhus
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2020-06-04
- **Primary completion:** 2030-12-31
- **Final completion:** 2030-12-31
- **Target enrollment:** 60 (ESTIMATED)
- **Last updated:** 2024-05-17

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04589299

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04589299, "Subcutaneous Immunoglobulin in De-novo CIDP (SIDEC)". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT04589299. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*